SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Pathways (CLPA) -- Ignore unavailable to you. Want to Upgrade?

To: Epicenter who wrote (58)12/12/1998 11:50:00 PM
From: bob  Read Replies (1) | Respond to of 566
 
Epicenter,

Thanks for the post. I had heard but didn't get around to posting it. Are you a shareholder? Just curious. What do you
think of their product Prevatac? Great announcement friday, can't
wait until it gets published in a peer reviewed journal.

Bob



To: Epicenter who wrote (58)12/15/1998 1:38:00 PM
From: Beltropolis Boy  Read Replies (1) | Respond to of 566
 
>Robert Towarnicki, the Cell Pathways CEO, will be on CNBC's Squawk Box at 8 AM on Monday, December 14.

for the benefit of the board, the aud & vid replays are available at this url.

(for the record, i don't have a position in CLPA.)

mktnews.nasdaq.com\\www\nasdaq\news\msnbc\1998\12\14\NASDAQ_0810_16942.htm&usymbol=clpa&logo=True&companyname=Cell+Pathways%2C+Inc%2E


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News